{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:46:48Z","timestamp":1789958808255,"version":"4.0.1"},"reference-count":28,"publisher":"Computers, Materials and Continua (Tech Science Press)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2015,11,25]]},"abstract":"<jats:p>We aimed to explore the underlying mechanism of peripheral myelin protein 22 (PMP22) in the development of chronic myeloid leukemia (CML). The level of PMP22 expression in CD34<jats:sup>+<\/jats:sup> cells isolated from CML patients\u2019 bone marrow samples (BMMCs) and peripheral blood samples\n (PBMCs) was determined by RT-PCR. In addition, PMP22-siRNA and scrambled control siRNA were transfected into human CML cell line K562 with Lipofectamine 2000 reagent. Cell viability and apoptosis were, respectively, determined by MTT assay and flow cytometry. Besides, the level of caspase\n 3 and Bcl-xL was then detected using Western blot. The level of PMP22 expression in CML patients\u2019 CD34<jats:sup>+<\/jats:sup> cells isolated from both PBMCs and BMMCs was significantly higher than the control group. PMP22 expression in K562 cells was successfully knocked down by siRNA. MTT analysis\n showed that knockdown of PMP22 inhibited the proliferation of CML cells. Flow cytometry showed that knockdown of PMP22 promoted the apoptosis of CML cells. Besides, Bcl-xL expression markedly decreased, while the expression of caspase 3 in CML cells significantly increased after knockdown\n of PMP22 expression. Our findings indicate that high expression of PMP22 may promote cell proliferation and inhibit cell apoptosis via upregulation of Bcl-xL or inhibition of caspase 3 activation, and thus may contribute to the development of CML. PMP22 may serve as a novel therapeutic target for the treatment of CML.<\/jats:p>","DOI":"10.3727\/096504015x14410238486603","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T16:58:30Z","timestamp":1448125110000},"page":"259-265","source":"Crossref","is-referenced-by-count":3,"title":["Knockdown of Peripheral Myelin Protein 22 Inhibits the Progression of Chronic Myeloid Leukemia"],"prefix":"10.32604","volume":"22","author":[{"given":"Hui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Hematology, The Affiliated Hospital of Yan'an University, Yan'an, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-qin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-bao","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","reference":[{"key":"b1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(07)61165-9","article-title":"Chronic myeloid leukaemia","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"b2","first-page":"103","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume-title":"Landmarks in medical genetics: Classic papers with commentaries","year":"2004"},{"key":"b3","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"b4","first-page":"430","article-title":"Management of patients with resistant or refractory chronic myelogenous leukemia","volume":"22","year":"2008","journal-title":"Oncology (Williston Park)"},{"key":"b5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00277-005-1039-z","article-title":"Chronic myeloid leukemia: A model for oncology","volume":"84","year":"2005","journal-title":"Ann. Hematol."},{"key":"b6","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","year":"2005","journal-title":"Blood"},{"key":"b7","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","article-title":"Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"362","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"b8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.leu.2404227","article-title":"Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis","volume":"20","year":"2006","journal-title":"Leukemia"},{"key":"b9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1476-4598-12-156","article-title":"Regulation of PMP22 mRNA by G3BP1 affects cell proliferation in breast cancer cells","volume":"12","year":"2013","journal-title":"Mol. Cancer"},{"key":"b10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1186\/1471-2407-10-682","article-title":"Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients","volume":"10","year":"2010","journal-title":"BMC Cancer"},{"key":"b11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1369\/jhc.4A6546.2005","article-title":"Expression analysis of PMP22\/Gas3 in premalignant and malignant pancreatic lesions","volume":"53","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"b12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.stem.2012.05.024","article-title":"Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells","volume":"11","year":"2012","journal-title":"Cell Stem Cell"},{"key":"b13","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","year":"2004","journal-title":"Blood"},{"key":"b14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cancergencyto.2003.11.003","article-title":"Characterization of PMP22 expression in osteosarcoma","volume":"152","year":"2004","journal-title":"Cancer Genet. Cytogen."},{"key":"b15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.leu.2404000","article-title":"Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status","volume":"20","year":"2006","journal-title":"Leukemia"},{"key":"b16","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1242\/dev.126.17.3781","article-title":"P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors","volume":"126","year":"1999","journal-title":"Development"},{"key":"b17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jcb.20558","article-title":"TGF-\u03b2 control of cell proliferation","volume":"96","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"b18","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood-2014-12-618090","article-title":"TGF-\u03b2 signaling in the control of hematopoietic stem cells","volume":"125","year":"2015","journal-title":"Blood"},{"key":"b19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1101\/gad.14.6.704","article-title":"PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22\/gas3 family","volume":"14","year":"2000","journal-title":"Gene Dev."},{"key":"b20","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death","volume":"74","year":"1993","journal-title":"Cell"},{"key":"b21","doi-asserted-by":"crossref","first-page":"e26014","DOI":"10.1371\/journal.pone.0026014","article-title":"Molecular basis of Bcl-XL-p53 interaction: Insights from molecular dynamics simulations","volume":"6","year":"2011","journal-title":"PloS One"},{"key":"b22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2008-02-137943","article-title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","volume":"113","year":"2009","journal-title":"Blood"},{"key":"b23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737","volume":"117","year":"2007","journal-title":"J. Clin. Invest."},{"key":"b24","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1182\/blood-2008-08-173310","article-title":"Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia","volume":"113","year":"2009","journal-title":"Blood"},{"key":"b25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1126\/science.1115035","article-title":"Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis","volume":"311","year":"2006","journal-title":"Science"},{"key":"b26","first-page":"227","article-title":"Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3","volume":"26","year":"2006","journal-title":"Anticancer Res."},{"key":"b27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajh.20542","article-title":"Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib","volume":"81","year":"2006","journal-title":"Am. J. Hematol."},{"key":"b28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000140359","article-title":"Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation","volume":"54","year":"2008","journal-title":"Chemotherapy"}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/or\/2015\/00000022\/f0020005\/art00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:06:25Z","timestamp":1658138785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/096504015X14410238486603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11,25]]}},"alternative-id":["0965-0407(20151125)22:5L.259;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504015x14410238486603","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,25]]}}}